Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disordersPriscila Chiavellini，Martina Canatelli-Mallat，Marianne Lehmann，Rodolfo G.Goya，Gustavo R.Morel469-476
Pentadecapeptide BPC 157 and the central nervous systemJak?a Vukojevi?，Marija Milavi?，Darko Perovi?，Spomenko Ili?，Andrea Zemba ?ili?，Nata?a ?uran，Sanja ?trbe，Zoran Zori?i?，Igor Filip?i?，Petrana Bre?i?，Sven Seiverth，Predrag Sikiri?482-487
The short form of the SUR1 and its functional implications in the damaged brainIván Alquisiras-Burgos，Javier Franco-Pérez，Moisés Rubio-Osornio，Penélope Aguilera488-496
Promise of metformin for preventing age-related cognitive dysfunctionLeelavathi N.Madhu，Maheedhar Kodali，Ashok K.Shetty503-507
Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamineAngela De Iuliis，Ennio Montinaro，Giuseppe Fatati，Mario Plebani，Carlo Colosimo523-533
